NCT01616615View on ClinicalTrials.gov

Aspirin for the Enhancement of Trophoblastic Invasion in Women With Abnormal Uterine Artery Doppler at 11-14 Weeks of Gestation

PHASE2CompletedINTERVENTIONAL

Enrollment

190

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions

Placental Insufficiency

Interventions

DRUG

Aspirin

150 mg/day oral use

DRUG

placebo

1 capsule / day oral use

Trial Locations (3)

50009

Hospital Clínico Lozano Blesa, Zaragoza

08028

Hospital Clinic of Barcelona, Barcelona

Institut Dexeus, Barcelona

All Listed Sponsors

lead

Sara Varea

OTHER

NCT01616615 - Aspirin for the Enhancement of Trophoblastic Invasion in Women With Abnormal Uterine Artery Doppler at 11-14 Weeks of Gestation | Biotech Hunter | Biotech Hunter